Connect to other sites within the UBM Medica Network
Maintenance with Atypical Antipsychotic Improves Depressive Symptoms in Bipolar Disorder
Findings are from an open-label extension study of lurasidone, conducted with patients in a private practice setting.
Bipolar Disorder Patients Benefit from Psychological Interventions
Evidence for the effects of psychosocial interventions is of low quality but study authors urge more research to identify optimal techniques.
Genetic Analysis Reveals Risk Region for Bipolar Disorder
Scientists have identified a single nucleotide polymorphism that appears to be associated with gene expression and susceptibility to bipolar disorder.
Elevated C-reactive Protein Increases Risk of Late-onset Bipolar Disorder
What impact should this recent finding have on clinical practice?
Patient Insight Affects the Efficacy of Antipsychotics in Acute Mania
Does good insight at start of pharmacologic treatment enhance outcomes?
Newer Drugs Used to Initiate Treatment for Bipolar Disorder
Newer classes of drugs are being chosen over traditional agents as treatment for patients newly diagnosed with bipolar disorder.
Bipolar Patients Display Persistent Cognitive Impairment
This study found a higher number of past manic episodes had the strongest correlation with the poorest outcomes in verbal memory testing.
Lithium Associated with Increased Chronic Kidney Disease
Lithium therapy in bipolar disorder is associated with chronic kidney disease but not with an increased rate of end-stage disease.
Second-generation Antipsychotics Ascend as Frontline Agents
What would lead clinicians to prescribe a novel antipsychotic as first-line therapy for manic symptoms over standard bipolar agents like lithium and valproate?
By clicking Accept, you agree to become a member of the UBM Medica Community.